MR

Michel Rathbone

AP Aventis Pharmaceuticals: 4 patents #68 of 454Top 15%
📍 Schreiber, CA: #160 of 2,446 inventorsTop 7%
Overall (All Time): #640,346 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10520491 Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors Shucui Jiang, Francesco Caciagli, Renata Ciccarelli, Patrizia Ballerini, Patrizia Di Iorio +2 more 2019-12-31
10012641 G-protein-coupled-receptor-22-transformed cell lines and methods of use thereof to identify binding compounds Shucui Jiang, Francesco Caciagli, Renata Ciccarelli, Patrizia Ballerini, Patrizia Di Iorio +2 more 2018-07-03
7534803 Method of treating demyelinating diseases or conditions Craig Smith, Margaret Petty, David Rampe 2009-05-19
7230015 Method of treating of demyelinating diseases or conditions Craig Smith, Margaret Petty, David Rampe 2007-06-12
7179821 Method of treating of demyelinating diseases or conditions Craig Smith, Margaret Petty, David Rampe 2007-02-20
6967210 Method of treating of demyelinating diseases or conditions Craig Smith, Margaret Petty, David Rampe 2005-11-22
6350752 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use Alvin J. Glasky 2002-02-26
5801184 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use Alvin J. Glasky 1998-09-01